LONDONGlaxoSmithKline PLCs diabetes treatment albiglutide was approved for use by US regulators Tuesday after a series of drugdevelopment setbacks for the company Albiglutide was approved for use in Europe in March under the brand name Eperzan It belongs to a class of drugs called GLP receptor agonists which work by stimulating the bodys natural production of insulin and help regulate bloodsugar levels Glaxo
  